Form 4: Walgreens Boots Alliance SVP Richard P. Gates Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Richard P. Gates, SVP and Chief Pharmacy Officer of Walgreens Boots Alliance, reports acquisition and disposition of company stock related to performance share awards and tax obligations.

Summary

  • Richard P. Gates, SVP and Chief Pharmacy Officer of Walgreens Boots Alliance, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
  • On October 23, 2024, Mr. Gates acquired 2,120 shares of common stock upon settlement of a performance share award granted on November 1, 2021, under the company's 2021 Omnibus Incentive Plan.
  • On the same day, he disposed of 621 shares to satisfy tax withholding obligations related to the award settlement at a price of $9.35 per share.
  • Following these transactions, Mr. Gates beneficially owns 79,473 shares of Walgreens Boots Alliance common stock, which includes shares underlying restricted stock units issued in lieu of dividends.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations. There's no indication of unusual activity or significant shifts in ownership that would warrant a stronger positive or negative sentiment.

Positives

  • The acquisition of shares through the performance share award indicates that Mr. Gates has met certain performance criteria, which could be viewed positively.

Negatives

  • The disposition of shares to cover tax obligations, while routine, reduces Mr. Gates' direct holdings in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates

DateDescription
November 1, 2021Date of grant for the performance share award.
October 15, 2024Date through which shares underlying restricted stock units issued in lieu of dividends are included.
October 23, 2024Date of the reported transactions (acquisition and disposition of shares).
October 25, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.